Fortress Biotech, Inc. (FBIO) is a publicly traded Healthcare sector company. As of November 19, 2026, FBIO trades at $1.78 with a market cap of $63.30M and a P/E ratio of 0.62. FBIO moved -5.82% today. Year to date, FBIO is -58.27%; over the trailing twelve months it is -31.46%. Its 52-week range spans $1.33 to $4.53. Analyst consensus is buy with an average price target of $5.00. Rallies surfaces FBIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
FBIO financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. FBIO recently traded at $1.78. Market cap is $63.30M. P/E ratio is 0.62. Revenue is $68.47M.
| Metric | Value |
|---|---|
| Price | $1.78 |
| Market Cap | $63.30M |
| P/E Ratio |
| 0.62 |
| EPS | $3.26 |
|---|
| Dividend Yield | 0.00% |
|---|
| 52-Week High | $4.53 |
|---|
| 52-Week Low | $1.33 |
|---|
| Volume | 188.28K |
|---|
| Avg Volume | 0 |
|---|
| Revenue (TTM) | $68.47M |
|---|
| Net Income | $141.19M |
|---|
| Gross Margin | 65.59% |
|---|
1 analysts cover FBIO: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.00.